The Division of Oncology is dedicated to developing multidisciplinary and lifesaving treatments for people worldwide who are affected by cancer. At the forefront of ground breaking treatments for cancer, our faculty is involved in more than 100 clinical trials to develop diagnostic and therapeutic approaches to various types of cancer.
Brain tumors integrate in neural wiring
Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a Stanford study has found.
Chair of epidemiology and population health named
Melissa Bondy has been appointed chair of the Department of Epidemiology and Population Health and associate director for population sciences at the Stanford Cancer Institute.
Irving Weissman honored for stem cell, cancer work
Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.
No chemo for some with leukemia
A large multicenter clinical trial led by Stanford physician Tait Shanafelt, MD, indicates that people with chronic lymphocytic leukemia may forgo chemotherapy in favor of new, targeted treatments.
New ‘don’t eat me’ signal discovered
Cancer cells are known to protect themselves using proteins that tell immune cells not to attack them. Stanford researchers have discovered a new “don’t eat me” signal, and blocking it may make cancer cells vulnerable to attack by the immune system.
Conferences and Workshops
New courses are added regularly— please check back often
Non-Stanford CME Courses of Interest
17th Multidisciplinary Management of Cancers: A Case-Based Approach
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.